사회: 허내윤 (부산울산경남지회 총무이사)
| 10:00-10:05 | 환영사 | 신정우 (부산울산경남지회 회장) |
| 10:05-10:10 | 격려사 | 권영오 (대한간학회 회장) |
| 10:10-11:50 | Session 1. Surveillance of HCC in an HBV-Endemic Area |
권영오 (경북의대), 이연재 (인제의대) |
| 10:10-10:30 | Current Epidemiology and Disease Burden of HCC in Korea | 정준호 (울산의대) |
| 10:30-10:50 | Identifying High-Risk Patients for HCC and Preventing HCC Development | 허내윤 (인제의대) |
| 10:50-11:10 | Optimal Surveillance Intervals and Modalities for HCC: Present and Future Perspectives | 홍영미 (부산의대) |
| 11:10-11:30 | Technology and Applications of Liquid Biopsy for Early Detection and Prediction of HCC | 정승원 (순천향의대) |
| 11:30-11:50 | Discussion | |
| 11:50-12:50 | Lunch | |
| 12:50-14:30 | Session 2. Current Issues in the Diagnosis of HCC: Imaging vs. Pathology |
박능화 (울산의대), 김윤준 (서울의대) |
| 12:50-13:10 | Radiologic Diagnosis of HCC and Differential Diagnoses | 김석 (부산의대) |
| 13:10-13:30 | Imaging Findings Related to HCC Prognosis and Their Practical Implications | 이형진 (연세의대) |
| 13:30-13:50 | Clinical Role of Liver Biopsy in the Diagnosis of HCC: Is It Time to Reconsider? | 이주호 (차의과학대) |
| 13:50-14:10 | The Role of Tumor Microenvironment in the Treatment Response and Prognosis of HCC | 유수종 (서울의대) |
| 14:10-14:30 | Discussion | |
| 14:30-14:50 | Coffee Break | |
| 14:50-16:30 | Session 3. Advanced Therapeutic Approaches to Cure or Control HCC |
김경식 (연세의대), 허정 (부산의대) |
| 14:50-15:10 | Technical and Medical Approaches to Enhance HCC Outcomes in Resection and Transplantation | 김석환 (충남의대) |
| 15:10-15:30 | Locoregional Treatments for Single or Multinodular HCC: Ablation vs. Intra-Arterial Therapy vs. Radiation Therapy | 박수영 (경북의대) |
| 15:30-15:50 | Advances beyond Standard Therapy for Intermediate-Stage HCC | 우현영 (부산의대) |
| 15:50-16:10 | Individual Strategies for Sequential Systemic Treatment in Advanced HCC Patients | 황상연 (동남권원자력의학원) |
| 16:10-16:30 | Discussion | |
| 16:30-16:35 | 맺음말 및 경품추첨 | 김윤준 (대한간학회 이사장) |